HIGH CREST FUNCTIONAL MEDICINE, LLC v. HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY, INC.

CourtDistrict Court, D. New Jersey
DecidedAugust 28, 2019
Docket2:15-cv-08876
StatusUnknown

This text of HIGH CREST FUNCTIONAL MEDICINE, LLC v. HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY, INC. (HIGH CREST FUNCTIONAL MEDICINE, LLC v. HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY, INC.) is published on Counsel Stack Legal Research, covering District Court, D. New Jersey primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
HIGH CREST FUNCTIONAL MEDICINE, LLC v. HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY, INC., (D.N.J. 2019).

Opinion

UNITED STATES DISTRICT COURT DISTRICT OF NEW JERSEY

Chambers of Martin Luther King Federal Building Leda Dunn Wettre & U.S. Courthouse 50 Walnut Street United States Magistrate Judge Newark, NJ 07101 (973) 645-3574

August 28, 2019 To: All counsel of record REPORT & RECOMMENDATION Re: High Crest Functional Medicine, LLC et al. v. Horizon Blue Cross Blue Shield of New Jersey, Inc. et al, Civ, A. No. 15-8876 (MCA) (LDW) Dear Counsel: This Report and Recommendation addresses the application of plaintiffs High Crest Functional Medicine, LLC and Michael Segal (the “Segal Parties”) to voluntarily withdraw without prejudice their legal malpractice counterclaim to an attorney lien petition filed by their former counsel Clinton Brook & Peed (“CBP”). (ECF No. 243). CBP opposes this application and requests instead that the Court convert its attorney lien petition to a motion for attorneys’ fees that would proceed essentially as a case-within-a-case. (ECF No. 244). For the reasons that follow, the Court respectfully recommends that the application to voluntarily withdraw the legal malpractice counterclaim be GRANTED and, as a result, the pending motion to dismiss the counterclaim (ECF No. 231) be TERMINATED AS MOOT. Additionally, the Court recommends that CBP’s application to convert its lien into a fee petition be DENIED. The Court omits the lengthy and exceedingly complicated procedural history of the underlying matter in this case, which generally involves claims by out-of-network medical service providers for wrongful denial of insurance benefits, and addresses only the more recent developments that are relevant to the instant disputes. In a Letter Opinion and Order dated October 3, 2017, this Court granted CBP’s motion to withdraw as counsel for plaintiffs the Segal Parties, Neelendu and Stephanie Bose, and the Boses’ wholly-owned corporate entities (the “Bose Parties”); the Segal Parties have since made public that the basis for CBP’s withdrawal was an alleged concurrent conflict of interest in violation of the New Jersey Rules of Professional Conduct. (ECF Nos. 166, 227). Following CBP’s withdrawal, this Court conducted a settlement conference at which the parties reached a settlement in principle, (ECF No. 206), and this matter was administratively terminated on June 28, 2018. (ECF No. 210). At some point thereafter, CBP became aware of the settlement in this action, and on October 8, 2018, it filed an attorney lien petition pursuant to N.J. Stat. Ann, § 2A:13-5 to recover $329,919.46 in unpaid legal fees from any settlement money plaintiffs may have obtained. (ECF No. 219). The Segal Parties responded to CBP’s lien petition and asserted a counterclaim for legal malpractice. (ECF No. 227).

Application to Voluntarily Withdraw Counterclaim In a stipulation dated April 15, 2019, the Segal Parties voluntarily dismissed with prejudice all claims asserted against defendant Horizon Blue Cross Blue Shield of New Jersey. (ECF No. 239). All parties apparently agree that, as a result of the Segal Parties’ voluntary dismissal of their claims, there is no recovery to which an attorney lien could attach. In other words, the attorney lien petition is moot. See Cole, Schotz, Bernstein, Meisel &Forman, P.A. v. Owens, 292 N.J. Super, 453, 460 (App. Div. 1996) (noting that “[a]n attorney’s lien is merely a right in the attorney to a lien on any judgment recovered for the attorney’s client,” but “([w]here there is no recovery, there is nothing to which the attorney’s lien can attach”). As there can be no viable affirmative claim in the lien petition, the Segal Parties seek leave to withdraw without prejudice their legal malpractice counterclaim thereto. CBP has already responded to the legal malpractice counterclaim and will not agree to a stipulation of dismissal, so the Segal Parties require leave of Court to voluntarily withdraw their counterclaim. Rule 41(a)(2) of the Federal Rules of Civil Procedure provides that ‘tan action may be dismissed at the [counterclaim] plaintiff's request only by court order, on terms that the court considers proper.” “Generally, a motion for dismissal should not be denied absent substantial prejudice” to the non-moving party. Sporn v. Ocean Colony Condominium Ass’n, 173 F. Supp. 2d 244, 255 (D.N.J. 2001) (quotation omitted). Factors relevant to a finding of substantial prejudice include “the expense of a second litigation, the effort and expense incurred by a [counterclaim] defendant in preparing for trial in the current case, the extent to which the current case has progressed, and [counterclaim] plaintiff's diligence in bringing the motion to dismiss.” /d, (quotation omitted). Indeed, “courts have followed the principle that dismissal should be allowed unless the [counterclaim] defendant will suffer some plain legal prejudice other than the mere prospect of a second lawsuit.” United States ex rel. Haskins v. Omega Inst, Inc., 11 F. Supp. 2d 555, 570 (D.N_J. 1998). Here, the ancillary lien petition/malpractice counterclaim has only minimally progressed. CBP filed its lien petition in October 2018, the Segal Parties responded and asserted their counterclaim in January 2019, and CBP moved to dismiss the counterclaim in March 2019, However, the Court entered an order extending sine die responsive briefing on the motion to dismiss while it has endeavored to resolve these issues consensually at numerous conferences, and no discovery has been taken. (ECF No, 233). Progress in the ancillary fee matter has been further complicated by the fact that the lien petition is asserted not only against the Segal Parties, but also against CBP’s former clients the Bose Parties, who are in the midst of bankruptcy proceedings and take the position that the attorney lien matter is subject to an automatic bankruptcy stay. (ECF No. 225). Thus, although the attorney lien petition has been pending for some time, nothing of note has occurred, and certainly nothing that would have required a significant outlay of attorneys’ fees by CBP. See Atkinson v. Forest Research Inst., Inc., Civ. A. No. 13-4703, 2015 WL 790220, at *3 (D.N.J. Feb. 25, 2015) (granting Rule 41(a)(2) motion where “discovery so far has been minimal. No trial date has been set, and no dispositive motions are pending. A motion to dismiss... was denied by this Court on June 18, 2014. Otherwise, the parties most recently submitted proposed discovery deadlines for the Court’s consideration. Whatever efforts and costs incurred by Defendants in this case that could be deemed wasted are not substantial enough to provide grounds to deny Plaintiff's motion”). Furthermore, the Segal Parties have been reasonably diligent in bringing their application for voluntarily dismissal, and there is no suggestion that they wish to withdraw their counterclaim to avoid an adverse judgment or to seek a more favorable forum. The Court recognizes that CBP has been living in the shadow of allegations of legal malpractice and

would prefer early resolution of the counterclaim on the merits, but that preference does not rise to the level of prejudice justifying denial of the Segal Parties’ application to withdraw their counterclaim. As CBP has made no showing of substantial prejudice that would result from voluntary dismissal of the legal malpractice counterclaim without prejudice, the Court recommends that the motion be granted. As a result of this voluntarily dismissal, the pending motion to dismiss the counterclaim (ECF No. 231) should be terminated as moot.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States Ex Rel. Haskins v. Omega Institute, Inc.
11 F. Supp. 2d 555 (D. New Jersey, 1998)
Sporn v. Ocean Colony Condominium Ass'n
173 F. Supp. 2d 244 (D. New Jersey, 2001)

Cite This Page — Counsel Stack

Bluebook (online)
HIGH CREST FUNCTIONAL MEDICINE, LLC v. HORIZON BLUE CROSS BLUE SHIELD OF NEW JERSEY, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/high-crest-functional-medicine-llc-v-horizon-blue-cross-blue-shield-of-njd-2019.